Where also Slovak scientists can get funds for R & D projects if they want to participate in the global fight against coronavirus infection and related health, economic and social impacts. 1. IMI's call for the innovative medicine initiative (IMI) launched an accelerated call of 03.03.2020 worth 45 million. To support projects to develop COVID-19 diagnostics and medicines. To submit a project, it is necessary to create or participate in consortia. Deadline is 31.03.20. For those interested in the challenge, it is good to see what was said on a special webinar about the challenge. There are presentations, a webinar as well as a list of participants where potential consortium partners could be found. Slovak researchers can contact these participants and discuss possible entry into the consortium. It is a unique ad hoc opportunity to enter an otherwise completely closed club if you offer interesting expertise. The European Virus Archive - GLOBAL (EVAg) The European Virus Archive (EVAg) The European Virus Archive has registered more than 200 requests from 55 countries for access to information enabling the development of diagnostics.3. Like EVAg, the PREPARE project is an existing project, a network that increases hospital preparedness for similar outbreaks of infectious diseases4. The GLOPID-R network (GLOBAL RESEARCH COLLABORATION FOR INFECTIOUS DISEASE PREPAREDNESS) is very interesting, which has responded rapidly to the coronavirus epidemic, cooperates closely with WHO and defines research priorities for the fight against coronavirus. You can find various resources on their website to fund research into the fight against coronavirus, and there is also an overview of what individual European countries are offering, most often for national research teams. A very interesting feature of this network is the creation of a global research roadmap that defines gaps in the knowledge of coronavirus infection, defines research priorities and sets out in very detail what should ever be achieved. For those interested, the European Commission has created the coronavirus response team and you can access many relevant information on its website. One of the options for supporting COVID-19 research outside the EU is also the combined efforts of the Bill & Melinda Gates Foundation together with Wellcome and Mastercard, who give USD 125 million to The Covid-19 Therapeutics Accelerator. We believe that the information provided will help Slovak researchers to engage in research activities to help mankind fight

COVID-19 and possibly other infectious diseases. After all, we have excellent scientists, among others, who are developing antimicrobials, experts in viral diseases, sequencing or the Slovacrin network, which can support academic clinical trials such as new anti-coronavirus drugs and its effects. In the interest of better information, we are addressing anyone who has further information on research grants, which could also be used by Slovak researchers to provide us with this information directly to info@biohub.sk or ivv@health.gov.sk, we are happy to move them further to the scientific community.